Back to Search
Start Over
Supplementary Figure 4 from mTOR Kinase Inhibitor AZD8055 Enhances the Immunotherapeutic Activity of an Agonist CD40 Antibody in Cancer Treatment
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Figure 4 from mTOR Kinase Inhibitor AZD8055 Enhances the Immunotherapeutic Activity of an Agonist CD40 Antibody in Cancer Treatment
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....a5e284d259c7ab3673820c738fdf356d